Laboratorios Farmaceuticos Rovi S.A. Logo

Laboratorios Farmaceuticos Rovi S.A.

Integrated pharma firm developing prescription drugs and offering contract manufacturing services.

ROVI | MC

Overview

Corporate Details

ISIN(s):
ES0157261019
LEI:
95980020140005936480
Country:
Spain
Address:
JULIAN CAMARILLO 35, 28037 Madrid
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Laboratorios Farmaceuticos Rovi S.A. is a specialized and fully integrated pharmaceutical company founded in 1946. The company's core activities encompass the research, development, manufacturing, and commercialization of a range of pharmaceutical products, with a focus on prescription and hospital-grade medicines. In addition to its proprietary product pipeline, ROVI also provides contract manufacturing services to third parties, offering a comprehensive suite of solutions including production, testing, packaging, and storage.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-18 00:00
La Sociedad informa sobre los acuerdos adoptados por su Junta General Ordinaria…
Spanish 152.8 KB
2025-05-08 07:56
La Sociedad informa sobre el acuerdo de convocatoria de su Junta General Ordina…
Spanish 488.2 KB
2025-05-08 07:54
ROVI informa sobre la concesión de una subvención en su favor para el desarroll…
Spanish 171.1 KB
2025-05-08 07:39
La Compañía hace pública la presentación relativa a los resultados financieros …
Spanish 957.7 KB
2025-05-08 07:35
La Compañía hace público el comunicado de prensa relativo a los resultados fina…
Spanish 631.0 KB
2025-05-08 00:00
La Sociedad informa sobre el acuerdo de convocatoria de su Junta General Ordina…
Spanish 488.2 KB
2025-04-04 10:27
Operaciones sobre acciones propias efectuadas en el primer trimestre de 2025 en…
Portuguese 219.9 KB
2025-03-25 10:03
La Sociedad hace pública de nuevo la presentación en español relativa a la actu…
Spanish 2.3 MB
2025-03-25 08:00
La Sociedad hace pública la presentación relativa a la actualización de su estr…
Spanish 2.3 MB
2025-02-25 07:54
La Sociedad informa sobre los acuerdos adoptados por su Consejo de Administraci…
Spanish 85.6 KB
2025-02-25 07:49
La Sociedad hace pública la presentación de los resultados financieros del ejer…
Spanish 1.4 MB
2025-02-25 07:47
La Sociedad hace público el comunicado de prensa relativo a los resultados fina…
Spanish 672.9 KB
2025-02-25 07:15
La Sociedad remite el Informe Anual sobre remuneraciones de los consejeros del …
Spanish 236.7 KB
2025-02-25 07:10
La sociedad remite el Informe Anual de Gobierno Corporativo del ejercicio 2024
Spanish 3.5 MB
2025-02-25 00:00 English 615.4 KB

Automate Your Workflow. Get a real-time feed of all Laboratorios Farmaceuticos Rovi S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Laboratorios Farmaceuticos Rovi S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Laboratorios Farmaceuticos Rovi S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Immix Biopharma, Inc. Logo
Developing safer cell therapies for AL Amyloidosis and hematologic malignancies.
United States of America
IMMX
IMMUCELL CORP /DE/ Logo
Develops biotech health products for disease prevention in dairy and beef cattle.
United States of America
ICCC
ImmuneOncia Therapeutics, Inc. Logo
A biopharma firm developing immune checkpoint inhibitors for cancer immunotherapy.
South Korea
424870
ImmunityBio, Inc. Logo
Develops immunotherapies activating the immune system to fight cancer and infectious diseases.
United States of America
IBRX
Immuno-Biological Laboratories Co., Ltd. Logo
Develops and supplies immunological reagents and diagnostics for research and drug discovery.
Japan
4570
Immunocore Holdings plc Logo
Pioneering TCR bispecific immunotherapies for cancer, infectious, and autoimmune diseases.
United States of America
IMCR
Immunome Inc. Logo
Develops targeted oncology therapies, like ADCs, for cancers with high unmet needs.
United States of America
IMNM
Immuron Ltd Logo
Develops oral antibodies from bovine colostrum for digestive and immune health.
United States of America
IMRN
Imunon, Inc. Logo
Developing DNA-based immunotherapies for oncology and infectious diseases.
United States of America
IMNN
IN8BIO, INC. Logo
Clinical-stage biopharma developing gamma-delta T cell therapies for solid & hematological tumors.
United States of America
INAB

Talk to a Data Expert

Have a question? We'll get back to you promptly.